What type of study is this?

This is a Cross-Sectional Study study.

What question did this study set out to answer?

The study aims to evaluate the diagnostic performance of endocan as a noninvasive biomarker in fibrosis triage for MASLD.

February 16, 2026Postgraduate Medicine2 citations

View Full Paper

Noninvasive fibrosis triage in MASLD: diagnostic performance of endocan and endoglin (cross-sectional study)

DGDoğan Can GAVCARDokuz Eylül University NDNilay DanışDokuz Eylül University MAM. E. AkcaDokuz Eylül University

Key Points

The study aims to evaluate the diagnostic performance of endocan as a noninvasive biomarker in fibrosis triage for MASLD.
Cross-sectional study design
Assessment of endocan as a biomarker
Study participants included those with MASLD
Endocan demonstrated promising diagnostic performance
Valuable for guiding fibrosis triage and referral decisions

Abstract

Endoglin and endocan are promising, accessible noninvasive biomarkers that may support fibrosis triage and referral decisions in general internal medicine for MASLD. Prospective validation is warranted.

问 AI

Bookmark

View Full Paper

问 AI

Bookmark

View Full Paper

Noninvasive fibrosis triage in MASLD: diagnostic performance of endocan and endoglin (cross-sectional study)

Key Points

Abstract

Cite This Study